ArticleInterdisciplinary sciences, computational life sciences2023
LBCE-XGB: A XGBoost Model for Predicting Linear B-Cell Epitopes Based on BERT Embeddings.
Article in Interdisciplinary sciences, computational life sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- B-cell epitope prediction in the age of machine learning: advancements and challenges.Journal of translational medicine · 2026Review
- BLMPred: Predicting linear B-cell epitopes using pre-trained protein language models and machine learning.Computational and structural biotechnology journal · 2026Article
- Computational identification of B- and T-cell epitopes: a unified task taxonomy and review of databases, datasets, predictive pipelines, and gaps.Frontiers in immunology · 2026Review
- The Role of Endoplasmic Reticulum Stress in Polycystic Ovary Syndrome and Exploration of Potential Therapeutic Targets.Reproductive sciences (Thousand Oaks, Calif.) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Accurately detecting linear B-cell epitopes (BCEs) makes great sense in vaccine design, immunodiagnostic test, antibody production, disease prevention and treatment. Wet-lab experiments for determining linear BCEs are both expensive and laborious, which are not able to meet the recognition needs of modern massive protein sequence data. Instead, computational methods can efficiently identify linear BCEs with low cost. Although several computational methods are available, the performance is still not satisfactory. Thus, we propose a new method, LBCE-XGB, to forecast linear BCEs based on XGBoost algorithm. To represent the biological information concealed in peptide sequences, the embeddings of the residues were obtained from a pre-trained domain-specific BERT model. In addition, the other five types of attributes comprising amino acid composition, amino acid antigenicity scale were also extracted. The best feature combination was determined according to the cross-validation results. Against the models developed by other deep learning and machine learning algorithms, LBCE-XGB achieves the top performance with an AUROC of 0.845 for fivefold cross-validation. The results on the independent test set show that our model attains an AUROC of 0.838 which is substantially higher than other state-of-the-art methods. The outcomes indicate that the representations of BERT could be an effective feature in predicting linear BCEs and we believe that LBCE-XGB could be a useful medium for detecting linear B cell epitopes with high accuracy and low cost.
Indexed as
Identifiers
36646842What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.